Blood Screening and Typing Markets

Blood Screening and Typing Markets

Blood Screening and Typing Markets analyzes the infectious disease blood typing and the infectious disease blood screening opportunities, including complete revenue estimates of the blood screening and typing markets: global blood typing and screening revenues, 2015 and 2020 (ABO grouping, immunoassay screen, NAT screen); selected blood typing innovations; blood typing by country, 2015 (United States, Italy, Germany, UK, France, Spain, Japan, China, Other Asia, Latin America, ROW) (%); infectious disease blood typing market portion by manufacturer; immunoassay testing market by country, 2015 (United States, Italy, Germany, UK, France, Spain, Japan, China, Other Asia, Latin America, ROW) (%); selected new blood screening immunoassays; NAT blood screening market by country, 2015 (United States, Italy, Germany, UK, France, Spain, Japan, China, Other Asia, Latin America, ROW) (%); Selected new blood screen NAT tests and systems; and infectious disease blood screening test market share by company.

Blood typing and testing represents the cornerstone of ensuring that transfused blood is safe for the recipient and free of disease. The report provides a complete review of the blood screening and typing markets, discussing risk of contamination; viral inactivation by procedure; basic blood types; blood transfusion compatibility; PCR-based screening tests licensed by CBER; comparison of direct and indirect ELISA tests; laboratory screening of blood donations for transfusion-transmissible infections, number of countries; blood component usage; pathogens commonly tested in donated blood units; selected pathogen screening innovations.

Grifols and Roche Diagnostics are among the manufacturers discussed in the report’s competitive analysis.